Medical Device & MedTech Layoffs in 2025: A Roundup

In 2025, as market pressures intensify and companies refocus on core strategic priorities, medical device and medtech companies have been forced to make tough decisions regarding their workforces.

These developments come amid a broader nationwide trend of workforce realignment, with both private and public entities, including the FDA’s recent rehires amid mass layoffs, adapting to ongoing pressures.

It is important to note that the medtech landscape has experienced major layoffs in previous years as well. In 2024, GRAIL reduced its workforce by 30% as part of a corporate restructuring to focus on its core multi-cancer early detection business, while BD (Becton Dickinson) cut 200 jobs at its Israeli manufacturing plant amid efforts to streamline operations.

Medtronic, one of the world’s largest medtech companies, also announced significant workforce reductions in 2024.

These examples serve as reminders that workforce adjustments are an ongoing trend in the industry.

This roundup will cover layoffs in the US throughout 2025, spotlighting both finalized and planned reductions in staff.

Whether driven by leadership changes, restructuring efforts or shifts in market demand, these adjustments underscore the evolving landscape in medtech.

In this Xtalks blog, readers can expect to find key coverage from leading medtech companies, including established industry giants and emerging innovators.

Hyperfine Layoffs 2025

Hyperfine reduced its workforce by 18 positions in late January 2025. The cuts, mainly affecting technical staff, support its shift from product development toward a commercialization phase.

Acutus Medical Layoffs 2025

Acutus Medical cut approximately 115 positions — about 70% of its workforce — in response to a strategic partnership with Medtronic, aimed at reducing operating costs and streamlining its cardiac device operations.

Illumina Layoffs 2025

Illumina plans to eliminate 96 positions at its San Diego headquarters between April and August 2025. This targeted reorganization is designed to align resources with its core genomics priorities.

Staar Surgical Layoffs 2025

Staar Surgical has announced plans to cut 115 positions, effective April 21, 2025, primarily at its Monrovia, CA facility, in response to a slowdown in market demand, especially in China.

Cepheid Layoffs 2025

Cepheid, a molecular diagnostics company, is laying off 167 employees across its California sites due to decreased demand for its COVID-19 tests.

Solventum Layoffs 2025

Solventum, a spinoff from 3M, is eliminating 800 positions, including 110 in Minnesota, as part of a restructuring plan aimed at saving $120 million annually.

Labcorp Layoffs 2025

Labcorp is closing its Los Angeles facility, resulting in 73 layoffs as the company restructures its consumer genetics business.

AMT Medical (Velocity Medtech) Layoffs 2025

AMT Medical, operating as Velocity Medtech, permanently laid off 70 employees at its Monroe, Washington site, as of April 24, 2025. The reduction is part of an organizational consolidation plan.

Cardinal Health Layoffs 2025

Cardinal Health implemented workforce reductions within its global medical products and distribution segment in response to projected US tariff impacts totaling $200 million to $300 million in FY2026. Specific job loss figures were not disclosed.

Medtronic Layoffs 2025

Medtronic confirmed workforce reductions at its Coon Rapids, Minnesota research facility. The layoffs affect R&D roles and are part of a larger restructuring across multiple business units. The number of layoffs was not disclosed.

GE HealthCare Adjustments 2025

GE HealthCare has warned of a potential $500 million financial impact from US tariffs on medical technology components. While no layoffs have been announced, the company indicated it may pursue cost control strategies, depending on the duration and extent of the tariff enforcement.

The Joint Commission Layoffs 2025

The Joint Commission laid off a number of administrative employees as part of efforts to modernize its operational structure and shift toward digital systems.

Accelerate Diagnostics Layoffs 2025

Accelerate Diagnostics filed for Chapter 11 bankruptcy and announced plans to sell substantially all assets. While no employee figures were disclosed, the restructuring is expected to involve workforce reductions across its diagnostic operations.

Philips Trade-Linked Workforce Measures 2025

Philips has revised its 2025 earnings outlook due to tariff-related pressures, projecting an approximately $286 million to $343 million impact from US-China trade tensions. The company said it is exploring cost reduction options — including pricing adjustments and localized production — while acknowledging that workforce-related actions remain under consideration.

If you want your company to be featured on Xtalks.com, please email [email protected].